132 related articles for article (PubMed ID: 9636858)
1. Comparison of two methods for the assessment of delayed-type hypersensitivity skin responses in patients with human immunodeficiency virus infection.
Martínez-Marcos FJ; López-Cortés LF; Pachón J; Alarcón A; Cordero E; Viciana P
Clin Infect Dis; 1998 Jun; 26(6):1330-4. PubMed ID: 9636858
[TBL] [Abstract][Full Text] [Related]
2. The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research.
Klein RS; Flanigan T; Schuman P; Smith D; Vlahov D
Int J Tuberc Lung Dis; 1999 Aug; 3(8):681-8. PubMed ID: 10460100
[TBL] [Abstract][Full Text] [Related]
3. Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients.
Raszka WV; Moriarty RA; Ottolini MG; Waecker NJ; Ascher DP; Cieslak TJ; Fischer GW; Robb ML
J Pediatr; 1996 Aug; 129(2):245-50. PubMed ID: 8765622
[TBL] [Abstract][Full Text] [Related]
4. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D
Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072
[TBL] [Abstract][Full Text] [Related]
5. Purified protein derivative tuberculin and delayed-type hypersensitivity skin testing in migrant farm workers at risk for tuberculosis and HIV coinfection.
Villarino ME; Geiter LJ; Schulte JM; Castro KG
AIDS; 1994 Apr; 8(4):477-81. PubMed ID: 8011250
[TBL] [Abstract][Full Text] [Related]
6. Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients.
Blatt SP; Hendrix CW; Butzin CA; Freeman TM; Ward WW; Hensley RE; Melcher GP; Donovan DJ; Boswell RN
Ann Intern Med; 1993 Aug; 119(3):177-84. PubMed ID: 8100691
[TBL] [Abstract][Full Text] [Related]
7. Delayed-type hypersensitivity anergy in human immunodeficiency virus-infected persons screened for infection with Mycobacterium tuberculosis.
Huebner RE; Schein MF; Hall CA; Barnes SA
Clin Infect Dis; 1994 Jul; 19(1):26-32. PubMed ID: 7948554
[TBL] [Abstract][Full Text] [Related]
8. Performance of antigens used in detecting delayed-type hypersensitivity in adolescents infected with the human immunodeficiency virus.
Rogers AS; Ellenberg JH; Douglas SD; Henry-Reid L; Peralta L; Wilson CM;
Clin Diagn Lab Immunol; 2001 Mar; 8(2):273-8. PubMed ID: 11238207
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus status and delayed-type hypersensitivity skin testing in Ugandan children.
Mandalakas AM; Guay L; Musoke P; Carroll-Pankhurst C; Olness KN
Pediatrics; 1999 Feb; 103(2):E21. PubMed ID: 9925867
[TBL] [Abstract][Full Text] [Related]
10. Selection of skin test antigens to evaluate PPD anergy.
Wright PW; Crutcher JE; Holiday DB
J Fam Pract; 1995 Jul; 41(1):59-64. PubMed ID: 7798066
[TBL] [Abstract][Full Text] [Related]
11. Gender differences in response to the multitest CMI skin test in the general population.
Vine MF; Stein L; Weigle K
Ann Allergy Asthma Immunol; 2000 Apr; 84(4):445-50. PubMed ID: 10795654
[TBL] [Abstract][Full Text] [Related]
12. [Clinical usefulness of Multitest in the evaluation of cellular immunity].
Feijoó RM; Ardiles A; Lemp P; King A; Villamán JJ; Parra A; Silva M
Rev Med Chil; 1996 Mar; 124(3):327-36. PubMed ID: 9008945
[TBL] [Abstract][Full Text] [Related]
13. Correlation between CD4+ lymphocyte counts, concurrent antigen skin test and tuberculin skin test reactivity in human immunodeficiency virus type 1-infected and -uninfected children with tuberculosis.
Madhi SA; Gray GE; Huebner RE; Sherman G; McKinnon D; Pettifor JM
Pediatr Infect Dis J; 1999 Sep; 18(9):800-5. PubMed ID: 10493341
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of delayed hypersensitivity: from PPD to poison ivy.
Rosenstreich DL
Allergy Proc; 1993; 14(6):395-400. PubMed ID: 8157162
[TBL] [Abstract][Full Text] [Related]
15. Three suitable antigens for delayed-type hypersensitivity skin testing in a tropical country like Thailand.
Siripassorn K; Charoenwongse P; Ruxrungtham K
Asian Pac J Allergy Immunol; 2006; 24(2-3):143-52. PubMed ID: 17136880
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated immunity assessed by Multitest CMI skin testing in infants and preschool children.
Kniker WT; Lesourd BM; McBryde JL; Corriel RN
Am J Dis Child; 1985 Aug; 139(8):840-5. PubMed ID: 4025264
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immunity in healthy and uremic adults assessed by in vivo and in vitro techniques. Validation of delayed hypersensitivity skin testing.
López M; Jerez J; González M; Arias M
Allergol Immunopathol (Madr); 1989; 17(1):21-8. PubMed ID: 2750637
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous delayed-type hypersensitivity responsiveness in lepromatous and borderline lepromatous leprosy patients as determined by MULTITEST CMI.
Walsh DS; Villahermosa LG; Balagon MV; Abalos RM; Fajardo TT; Tan EV; Cellona RV; Walsh GP
Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):518-26. PubMed ID: 10774662
[TBL] [Abstract][Full Text] [Related]
19. Delayed hypersensitivity skin testing to mumps and Candida albicans antigens is normal in middle-aged HTLV-I- and-II-infected U.S. cohorts.
Murphy EL; Wu Y; Ownby HE; Smith JW; Ruedy RK; Thomson RA; Ameti DI; Wright DJ; Nemo GJ;
AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1273-7. PubMed ID: 11559427
[TBL] [Abstract][Full Text] [Related]
20. Delayed-type hypersensitivity skin test responses to PPD and other antigens among BCG-vaccinated HIV-1-infected and healthy children and adolescents.
Costa NM; Albuquerque Md; Lins JB; Alvares-Junior JT; Stefani MM
Rev Soc Bras Med Trop; 2011 Oct; 44(5):542-5. PubMed ID: 21877065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
